Location: Home
  • search
  • go
  • Relate News
  • 4/20/2010IMS Health projects global drug sales to reach US$1.1 trillion by 2014...
  • 4/20/2010State Council issues 2010 healthcare reform action plan (with full sum...
  • 4/19/2010SinoPharm enters strategic alliance with Luoyang municipal government ...
  • 4/16/2010Eisai licenses China rights of Cinitapride Tartrate from Almirall
  • 4/15/2010PhytoMedical signs LOI with Shanghai Medicilon over IND for its anti-c...
  • 4/15/2010Sanofi-Aventis launches schizophrenia drug Solian in China
  • 4/15/2010More major reorganizations anticipated in Chinese pharma sector
  • 4/14/2010Hand-foot-mouth disease kills 94 Chinese children this year
  • 4/14/2010Radient Pharma to dispose Chinese subsidiary Jade Pharma
  • 4/14/2010Chinese nutritional supplement market to become the world’s largest t...
  • 4/14/2010MOH introduces new measures to promote awareness and treatment of hemo...
  • 4/13/2010State Council approves merger of SIPI into SinoPharm
  • 4/13/2010Baiyunshan Pharma gains US patent for new cephalosporin
  • 4/13/2010Roche expands position insulin delivery system market through Medingo ...
  • 4/11/2010Beijing Saike to launch first Chinese-made finished drug in the U.S. ...
  • 4/11/2010Novozymes builds new biopharma facility in Tianjin
  • 4/8/2010NMT licenses technology for generic hyperlipidemia drug to Beijing Win...
  • 4/8/2010MPI Research ends China JV with Medicilon
  • 4/8/2010Sanofi-Aventis opens China R&D center as BMS prepares to move its ...
  • 4/8/2010Public hospital reform trial regions submit implementation plans to th...
  • 4/8/2010Pfizer sponsors pharmacoeconomics training program at Fudan University...
  • 4/7/2010CAPC releases the 2009 ranking for the leading 100 Chinese retail phar...
  • 4/7/2010Pfizer funds Chinese drug research for drug-resistant tuberculosis
  • 4/7/2010ICON enters into alliance with Tigermed for CRO services in China
  • 4/7/2010SinoPharm in the process of acquiring Nanjing Pharmaceutical Group
  • 4/2/2010Excess capacity observed in the Chinese API sector
  • 4/1/2010Outpatient drug expenditures found to be much lower in Beijing’s comm...
  • 4/1/2010Prevalence and medical costs of headache rise in China
  • 4/1/2010XiAn company gains OTCBB listing through reverse merger
  • 4/1/2010Astellas to market Teijin's novel drug for hyperuricemia in China
  • Page:317/361 Total number of articles:10807: [First][<<] [315] [316] [317] [318] [319] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group